Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: A&G PHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-13 to 2020-01-26
Current total value of award: $14630.25
Description: MONOCLONAL ANTIBODY (MAB) DEVELOPMENT